Thus, surge in vision-related complications may promote the adoption of the therapeutic or corrective devices, which has led to a boost in the demand for bionic eye all over the world. Similarly, as per the International Agency for the Prevention of Blindness, in 2018, more than 21 million of Vietnamese required eye care services, Out of which over 3 million Vietnamese students are having eyesight problems. Furthermore, the rise in prevalence of ophthalmic diseases due to growing geriatric population, increasing funding by public and private organizations, and intensive research and development (R&D) focused on product innovation are the few factors responsible for the impressive CAGR of the market during the forecast period.Īccording to the World Health Organization, nearly 2.2 billion people were affected with vision impairment or blindness in October 2019, of which at least 1 billion people had preventable or unaddressed conditions around the world. Bionic eye is usually considered as artificial eye which can deliver visual sensation to the brain and often helps the people to improve the vision abilities, which is resulting in the higher market growth across the globe. Many devices and surgeries have been developed, typically modeled on the cochlear implant or bionic ear device, so as to heal the blindness of the individuals. Request To Download Sample of This Strategic Report: īionic eye, also referred to as visual prosthesis, is an experimental visual device used to restore the visual function of the patient experiencing partial or complete blindness. Global Bionic Eye Market is valued at approximately USD 183.5 million in 2019 and is anticipated to grow with a healthy growth rate of more than 12.7% over the forecast period 2020-2027. The structured analysis offers a graphical representation and a diagrammatic breakdown of the Bionic Eye Market by region. In addition, the report includes data on research & development, new product launches, product responses from the global and local markets by leading players. It provides detailed information about the structure and prospects for global and regional industries. Watson is on staff at the Straith Hospital for Special Surgery and Providence Hospital." Global Bionic Eye Market" report contains detailed information on factors influencing demand, growth, opportunities, challenges, and restraints. She then completed her residency in ophthalmology and vitreoretinal fellowship at the Illinois Eye and Ear Infirmary at the University of Illinois at Chicago.ĭr. Watson returned home to metro Detroit where she obtained her medical degree from Wayne State University in 2010 with distinction by the Alpha Omega Alpha (AOA) Honor Medical Society. Watson has authored numerous publications, including journal articles and book chapters, and presented research at many national and international meetings.Īfter graduating with a degree in biology from the Massachusetts Institute of Technology in 2006, Dr. Watson is board certified by the American Board of Ophthalmology and is a member of the American Academy of Ophthalmology and the American Society of Retina Specialists, including the Women in Retina section. Watson has over five years of experience in the diagnosis and treatment of medical and surgical retinal diseases, utilizing the most up-to-date techniques to treat a variety of conditions including diabetic eye disease, macular degeneration, retinal vascular occlusions, retinal detachments, macular holes, and epiretinal membranes.ĭr.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |